The Zydus Family Trust, a major shareholder in Zydus Lifesciences (formerly known as Cadila Healthcare Limited), a prominent pharmaceutical company, has bought a spacious apartment in Oberoi ...

Zydus Family Trust purchased a luxury apartment in Mumbai's Oberoi Realty project for ₹200 crore. Covering 17,384 sq ft, the apartment is part of the 'Oberoi 360 West'. The demand for luxury homes has ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Apalutamide Tablets, 60 mg (Erleada Tablets, 60 mg). Apalutamide is an ...

Drug maker Zydus Lifesciences Ltd on Tuesday (March 18) said it has received the final approval from the United States Food and Drug Administration (FDA) to manufacture and market apalutamide tablets, ...

Zydus Lifesciences Ltd has received USFDA approval to manufacture a generic version of Apalutamide tablets for prostate cancer treatment. The 60 mg tablets will be produced in Ahmedabad, addressing a ...

The companies behind the product pulls are Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, all three of which hail from India. The drugmakers are recalling seizure treatments ...

Sun Pharma and Zydus Pharmaceuticals recall products in the US due to manufacturing issues, according to the US FDA. The recalls affect Morphine Sulfate and Nelarabine Injection. New Delhi, Mar 16 ...

The New Jersey-based Sun Pharmaceutical Industries, Inc is recalling 9,840 bottles of Morphine Sulfate extended-release tablets for 'Failed Dissolution Specifications', the US health regulator ...

Drug maker Zydus Lifesciences Ltd on Friday (March 14) announced the successful completion of a United States Food and Drug Administration (USFDA) inspection at its API Unit 1 in Ankleshwar, Gujarat.

Ahmedabad: Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) has concluded a surveillance inspection with NIL observations at the group's API Unit 1, located at ...

Zydus Wellness is moving beyond just nutritional ... They want nutrition in various formats—bars, chips, and shakes,” says Arora. This positions Complan against emerging D2C protein brands ...

Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus ...